ZymoGenetics, Inc. (NASDAQ:ZGEN.DL)

CAPS Rating: No stars

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Recs

0
Player Avatar Tyrone85 (29.13) Submitted: 5/20/2009 12:00:47 AM : Outperform Start Price: $4.45 ZGEN.DL Score: +92.07

$4.43 heah to $10.00 or more

Report this Post Reply

Featured Broker Partners


Advertisement